<VariationArchive VariationID="7325" VariationName="NR_001566.2(TERC):n.108_111delCTGA" VariationType="Deletion" Accession="VCV000007325" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2013-04-04" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22364" VariationID="7325">
      <GeneList>
        <Gene Symbol="LOC110806306" FullName="telomerase RNA component (TERC) promoter" GeneID="110806306" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="169764689" stop="169765858" display_start="169764689" display_stop="169765858" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="TERC" FullName="telomerase RNA component" GeneID="7012" HGNC_ID="HGNC:11727" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="169764610" stop="169765060" display_start="169764610" display_stop="169765060" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="169482397" stop="169482847" display_start="169482397" display_stop="169482847" Strand="-" />
          </Location>
          <OMIM>602322</OMIM>
        </Gene>
      </GeneList>
      <Name>NR_001566.2(TERC):n.108_111delCTGA</Name>
      <CanonicalSPDI>NC_000003.12:169764947:AGTCAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="169764948" stop="169764951" display_start="169764948" display_stop="169764951" variantLength="4" positionVCF="169764947" referenceAlleleVCF="AAGTC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="169482736" stop="169482739" display_start="169482736" display_stop="169482739" variantLength="4" positionVCF="169482735" referenceAlleleVCF="AAGTC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.169482738_169482741del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.169482738_169482741del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.169764950_169764953del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.169764950_169764953del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016363.1" sequenceAccession="NG_016363" sequenceVersion="1" change="g.5110_5113del">
            <Expression>NG_016363.1:g.5110_5113del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_055509.2" sequenceAccession="NG_055509" sequenceVersion="2" change="g.362_365del">
            <Expression>NG_055509.2:g.362_365del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_001566.2" sequenceAccession="NR_001566" sequenceVersion="2" change="n.108_111delCTGA">
            <Expression>NR_001566.2:n.108_111delCTGA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_347" sequenceAccession="LRG_347">
            <Expression>LRG_347:g.5110_5113del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_347t1" sequenceAccession="LRG_347t1">
            <Expression>LRG_347t1:n.110_113del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA118715" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602322.0006" DB="OMIM" />
        <XRef Type="rs" ID="199422270" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NR_001566.2(TERC):n.108_111delCTGA AND Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2" Accession="RCV000007749" Version="4">
        <ClassifiedConditionList TraitSetID="8797">
          <ClassifiedCondition DB="MedGen" ID="C3553622">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2002-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NR_001566.2(TERC):n.108_111delCTGA AND Aplastic anemia" Accession="RCV000032556" Version="2">
        <ClassifiedConditionList TraitSetID="1918">
          <ClassifiedCondition DB="MedGen" ID="C0002874">Aplastic anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-05-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NR_001566.2(TERC):n.108_111delCTGA AND Dyskeratosis congenita, autosomal dominant 1" Accession="RCV001214506" Version="5">
        <ClassifiedConditionList TraitSetID="1583">
          <ClassifiedCondition DB="MedGen" ID="C4551974">Dyskeratosis congenita, autosomal dominant 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-20" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12090986</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15082312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15098033</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15319288</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17640862</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20022961</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21844345</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21931702</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22341970</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25612863</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301779</ID>
          <ID Source="BookShelf">NBK22301</ID>
        </Citation>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8797" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17341" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2</ElementValue>
                <XRef ID="MONDO:0013879" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2</ElementValue>
                <XRef Type="MIM" ID="614743" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602322.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFBMFT2</ElementValue>
                <XRef Type="MIM" ID="614743" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301408</ID>
                <ID Source="BookShelf">NBK1230</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="88" DB="Orphanet" />
              <XRef ID="C3553622" DB="MedGen" />
              <XRef ID="MONDO:0013879" DB="MONDO" />
              <XRef Type="MIM" ID="614743" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1918" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4604" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aplastic anemia</ElementValue>
                <XRef ID="Aplastic+Anemia/556" DB="Genetic Alliance" />
                <XRef ID="HP:0001915" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0015909" DB="MONDO" />
                <XRef ID="306058006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20234" />
                <XRef ID="20234" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="182040" DB="Orphanet" />
              <XRef ID="88" DB="Orphanet" />
              <XRef ID="C0002874" DB="MedGen" />
              <XRef ID="MONDO:0015909" DB="MONDO" />
              <XRef Type="MIM" ID="609135" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001915" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1583" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4974" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dyskeratosis congenita autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dyskeratosis congenita Scoggins type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 1</ElementValue>
                <XRef ID="MONDO:0007485" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DKCA1</ElementValue>
                <XRef Type="MIM" ID="127550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Variable</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6299" />
                <XRef ID="6299" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21610750</ID>
              </Citation>
              <XRef ID="1775" DB="Orphanet" />
              <XRef ID="C4551974" DB="MedGen" />
              <XRef ID="MONDO:0007485" DB="MONDO" />
              <XRef Type="MIM" ID="127550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27950" SubmissionDate="2018-03-20" DateLastUpdated="2023-05-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602322.0006_PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2" title="TERC, 4-BP DEL, 110GACT_PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2" />
        <ClinVarAccession Accession="SCV000027950" DateUpdated="2023-05-13" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-06-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 26-year-old man and his sister with telomere-related bone marrow failure (PFBMFT2; 614743), Vulliamy et al. (2002) found a 4-bp deletion (c.110-113GACT) in the TERC gene.</Attribute>
              <Citation>
                <ID Source="PubMed">12090986</ID>
              </Citation>
              <XRef DB="OMIM" ID="614743" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TERC" />
          </GeneList>
          <Name>TERC, 4-BP DEL, 110GACT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 110GACT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602322.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="92703" SubmissionDate="2013-01-08" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NR_001566.1:c.110_113delgact_NBK22301" title="NR_001566.1:c.110_113delgact and Dyskeratosis Congenita" />
        <ClinVarAccession Accession="SCV000056228" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-05-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NR_001566.1:c.110_113delgact</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Dyskeratosis Congenita</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK22301" />
            <XRef DB="OMIM" ID="609135" Type="MIM Number" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2721018" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="5726832|MedGen:C1851970" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001386189" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15098033</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17640862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22341970</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25612863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15319288</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17640862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20022961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15082312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21844345</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15082312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21844345</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21931702</ID>
          </Citation>
          <Comment>This variant occurs in the TERC gene, which encodes an RNA molecule that does not result in a protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with personal and family history of dyskeratosis congenita, aplastic anemia, and pulmonary fibrosis (PMID: 15098033, 17640862, 22341970, 25612863). ClinVar contains an entry for this variant (Variation ID: 7325). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects TERC RNA function (PMID: 15319288, 17640862, 20022961). This variant is located within the template/pseudoknot domain of the TERC RNA component, which is required for RNA or RNP stability (PMID: 15082312, 21844345). This variant is located in a region of TERC in which a significant number of disease causing variants have been reported (PMID: 15082312, 21844345, 21931702). These observations suggest that this may be a clinically significant region. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TERC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.169482736_169482739del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1851970" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2721018" TraitType="Disease" MappingType="XRef" MappingValue="C1851970" MappingRef="MedGen">
        <MedGen CUI="C4551974" Name="Dyskeratosis congenita, autosomal dominant 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27950" TraitType="Disease" MappingType="Name" MappingValue="PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2" MappingRef="Preferred">
        <MedGen CUI="C3553622" Name="Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="92703" TraitType="Disease" MappingType="Name" MappingValue="Dyskeratosis Congenita" MappingRef="Preferred">
        <MedGen CUI="C0265965" Name="Dyskeratosis congenita" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

